 The United States Patent and Trademark Office USPTO has issued a Notice of Allowance for Biofrontera Inc NASDAQ: BFRI titled Illumination for Photodynamic Therapy. The patent covers pain-reducing illumination protocol for photodynamic therapy PDT. 